干燥综合征

Nocturne G, Mariette X. Advances in understanding the pathogenesis of primary Sjogren's syndrome. Nat Rev Rheumatol. 2013 Sep;9(9):544-56. 摘要

Fox RI. Sjogren's syndrome. Lancet. 2005 Jul 23-29;366(9482):321-31. 摘要

Haugen AJ, Peen E, Hulten B, et al. Estimation of the prevalence of primary Sjogren's syndrome in two age-different community-based populations using two sets of classification criteria: the Hordland Health Study. Scand J Rheumatol. 2008 Jan-Feb;37(1):30-4. 摘要

Harris VM, Sharma R, Cavett J, et al. Klinefelter's syndrome (47,XXY) is in excess among men with Sjogren's syndrome. Clin Immunol. 2016 Jul;168:25-29.全文  摘要

Mavragani CP, Moutsopoulos NM, Moutsopoulos HM. The management of Sjogren's syndrome. Nat Clin Pract Rheumatol. 2006 May;2(5):252-61. 摘要

Venables PJ. Sjogren's syndrome. Best Pract Res Clin Rheumatol. 2004 Jun;18(3):313-29. 摘要

Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002 Jun;61(6):554-8.全文  摘要

Whitcher JP, Shiboski CH, Shiboski SC, et al; Sjogren's International Collaborative Clinical Alliance Research Groups. A simplified quantitative method for assessing keratoconjunctivitis sicca from the Sjogren's Syndrome International Registry. Am J Ophthalmol. 2010 Mar;149(3):405-15. 摘要

Hernández-Molina G, Avila-Casado C, Nuñez-Alvarez C, et al. Utility of the American-European Consensus Group and American College of Rheumatology Classification Criteria for Sjogren's syndrome in patients with systemic autoimmune diseases in the clinical setting. Rheumatology (Oxford). 2015 Mar;54(3):441-8. 摘要

Devauchelle-Pensec V, Mariette X, Jousse-Joulin S, et al. Treatment of primary Sjogren syndrome with rituximab: a randomized trial. Ann Intern Med. 2014 Feb 18;160(4):233-42. 摘要

1. Nocturne G, Mariette X. Advances in understanding the pathogenesis of primary Sjogren's syndrome. Nat Rev Rheumatol. 2013 Sep;9(9):544-56. 摘要

2. Fox PC. Autoimmune diseases and Sjogren's syndrome, an autoimmune exocrinopathy. Ann N Y Acad Sci. 2007 Mar;1098:15-21. 摘要

3. Anaya JM, Tobon GJ, Vega P, et al. Autoimmune disease aggregation in families with primary Sjogren's syndrome. J Rheumatol. 2006 Nov;33(11):2227-34. 摘要

4. Steinberg AD, Talal N. The coexistence of Sjogren's syndrome and systemic lupus erythematosus. Ann Intern Med. 1971 Jan;74(1):55-61. 摘要

5. Moutsopoulos HM, Webber BL, Vlagopoulos TP, et al. Differences in the clinical manifestations of sicca syndrome in the presence and absence of rheumatoid arthritis. Am J Med. 1979 May;66(5):733-6. 摘要

6. Foster H, Fay A, Kelly C, et al. Thyroid disease and other autoimmune phenomena in a family study of primary Sjogren's syndrome. Br J Rheumatol. 1993 Jan;32(1):36-40. 摘要

7. Alarcon-Segovia D, Ibanez G, Hernandez-Ortiz J, et al. Sjogren's syndrome in progressive systemic sclerosis (scleroderma). Am J Med. 1974 Jul;57(1):78-85. 摘要

8. Manthorpe R, Manthorpe T. Primary Sjogren's syndrome - epidemiology and prognosis. Akt Rheumatol. 2005;30:27-31.

9. Fox RI. Sjogren's syndrome. Lancet. 2005 Jul 23-29;366(9482):321-31. 摘要

10. Kabasakal Y, Kitapciglu G, Turk T, et al. The prevalence of Sjogren's syndrome in adult women. Scand J Rheumatol. 2006 Sep-Oct;35(5):379-83. 摘要

11. Kassan SS, Moutsopoulos HM. Clinical manifestations and early diagnosis of Sjogren syndrome. Arch Intern Med. 2004 Jun 28;164(12):1275-84.全文  摘要

12. Haugen AJ, Peen E, Hulten B, et al. Estimation of the prevalence of primary Sjogren's syndrome in two age-different community-based populations using two sets of classification criteria: the Hordland Health Study. Scand J Rheumatol. 2008 Jan-Feb;37(1):30-4. 摘要

13. Schein OD, Hochberg MC, Muñoz B, et al. Dry eye and dry mouth in the elderly: a population-based assessment. Arch Intern Med. 1999 Jun 28;159(12):1359-63.全文  摘要

14. Scofield RH, Kurien BT, Reichlin M. Immunologically restricted and inhibitory anti-Ro in monozygotic twins. Lupus. 1997;6(4):395-8. 摘要

15. Bolstad AI, Haga HJ, Wassmuth R, et al. Monozygotic twins with primary Sjogren's syndrome. J Rheumatol. 2000 Sep;27(9):2264-6. 摘要

16. Nordmark G, Alm GV, Ronnblom L. Mechanisms of disease: primary Sjogren's syndrome and the type I interferon system. Nat Clin Pract Rheumatol. 2006 May;2(5):262-9. 摘要

17. Gottenberg JE, Busson M, Loiseau P, et al. In primary Sjogren's syndrome, HLA class II is associated exclusively with autoantibody production and spreading of the autoimmune response. Arthritis Rheum. 2003 Aug;48(8):2240-5. 摘要

18. Scofield RH. Genetics of systemic lupus erythematosus and Sjogren's syndrome. Curr Opin Rheumatol. 2009 Sep;21(5):448-53. 摘要

19. Nagata Y, Inoue H, Yamada K, et al. Activation of Epstein-Barr virus by saliva from Sjogren's syndrome patients. Immunology. 2004 Feb;111(2):223-9.全文  摘要

20. Nakamura H, Kawakami A, Eguchi K. Mechanisms of autoantibody production and the relationship between autoantibodies and the clinical manifestations in Sjogren's syndrome. Transl Res. 2006 Dec;148(6):281-8. 摘要

21. Scheinfeld N. Sjogren syndrome and systemic lupus erythematosus are distinct conditions. Dermatol Online J. 2006 Jan 27;12(1):4.全文  摘要

22. Hammi AR, Al-Hashimi IH, Nunn ME, et al. Assessment of SS-A and SS-B in parotid saliva of patients with Sjogren's syndrome. J Oral Pathol Med. 2005 Apr;34(4):198-203. 摘要

23. Miller AV, Ranatunga SK, Francis ML, et al. Sjogren syndrome. August 2016. [internet publication].全文

24. Lemp MA. Dry eye (keratoconjunctivitis sicca), rheumatoid arthritis, and Sjogren's syndrome. Am J Ophthalmol. 2005 Nov;140(5):898-9. 摘要

25. Whitacre CC. Sex differences in autoimmune disease. Nat Immunol. 2001 Sep;2(9):777-80. 摘要

26. Ackerman LS. Sex hormones and the genesis of autoimmunity. Arch Dermatol. 2006 Mar;142(3):371-6. 摘要

27. Sullivan DA, Belanger A, Cermak JM, et al. Are women with Sjogren's syndrome androgen-deficient? J Rheumatol. 2003 Nov;30(11):2413-9. 摘要

28. Delaleu N, Jonsson R, Koller MM. Sjogren's syndrome. Eur J Oral Sci. 2005 Apr;113(2):101-13. 摘要

29. Liu K, Kurien BT, Zimmerman SL, et al. X chromosome dose and sex bias in autoimmune diseases: increased prevalence of 47,XXX in systemic lupus erythematosus and Sjogren's syndrome. Arthritis Rheumatol. 2016 May;68(5):1290-1300.全文  摘要

30. Harris VM, Sharma R, Cavett J, et al. Klinefelter's syndrome (47,XXY) is in excess among men with Sjogren's syndrome. Clin Immunol. 2016 Jul;168:25-29.全文  摘要

31. Mavragani CP, Moutsopoulos NM, Moutsopoulos HM. The management of Sjogren's syndrome. Nat Clin Pract Rheumatol. 2006 May;2(5):252-61. 摘要

32. Cimaz R, Casadei A, Rose C, et al. Primary Sjogren’s syndrome paediatric age: a multicentre survey. Eur J Pediatr. 2003 Oct;162(10):661-5. 摘要

33. Sumida T, Azuma N, Moriyama M, et al. Clinical practice guideline for Sjögren's syndrome 2017. Mod Rheumatol. 2018 May;28(3):383-408. 摘要

34. Romão VC, Talarico R, Scirè CA, et al. Sjögren's syndrome: state of the art on clinical practice guidelines. RMD Open. 2018 Oct 18;4(suppl 1):e000789.全文  摘要

35. Venables PJ. Sjogren's syndrome. Best Pract Res Clin Rheumatol. 2004 Jun;18(3):313-29. 摘要

36. Fox PC, Brennan M, Pillemer S, et al. Sjogren's syndrome: a model for dental care in the 21st century. J Am Dent Assoc. 1998 Jun;129(6):719-28. 摘要

37. Shiboski SC, Shiboski CH, Criswell L, et al; Sjogren's International Collaborative Clinical Alliance (SICCA) Research Groups. American College of Rheumatology classification criteria for Sjogren's syndrome: a data-driven, expert consensus approach in the Sjogren's International Collaborative Clinical Alliance cohort. Arthritis Care Res (Hoboken). 2012 Apr;64(4):475-87.全文  摘要

38. Scofield AK, Radfar L, Ice JA, et al. Relation of sensory peripheral neuropathy in Sjogren syndrome to anti-Ro/SSA. J Clin Rheumatol. 2012 Sep;18(6):290-3. 摘要

39. Pavlakis PP, Alexopoulos H, Kosmidis ML, et al. Peripheral neuropathies in Sjogren syndrome: a new reappraisal. J Neurol Neurosurg Psychiatry. 2011 Jul;82(7):798-802. 摘要

40. Agmon-Levin N, Kivity S, Tzioufas AG, et al. Low levels of vitamin-D are associated with neuropathy and lymphoma among patients with Sjogren's syndrome. J Autoimmun. 2012 Sep;39(3):234-9. 摘要

41. Napeñas JJ, Rouleau TS. Oral complications of Sjogren's syndrome. Oral Maxillofac Surg Clin North Am. 2014 Feb;26(1):55-62. 摘要

42. Al-Hashimi I, Khuder S, Haghighat N, et al. Frequency and predictive value of the clinical manifestations in Sjogren's syndrome. J Oral Pathol Med. 2001 Jan;30(1):1-6. 摘要

43. Soto-Rojas AE, Kraus A. The oral side of Sjogren syndrome. Diagnosis and treatment. A review. Arch Med Res. 2002 Mar-Apr;33(2):95-106. 摘要

44. Klasser GD, Balasubramaniam R, Epstein J. Topical review-connective tissue diseases: orofacial manifestations including pain. J Orofac Pain. 2007 Summer;21(3):171-84. 摘要

45. Liao MT, Chien WC, Wang JC, et al. Increased risk of bisphosphonate-related osteonecrosis of the jaw in patients with Sjögren's syndrome: nationwide population-based cohort study. BMJ Open. 2019 Feb 13;9(2):e024655.全文  摘要

46. Seneff S, Swanson NL, Koenig G, et al. Is GERD a Factor in Osteonecrosis of the Jaw? Evidence of Pathology Linked to G6PD Deficiency and Sulfomucins. Dis Markers. 2016 Sep 28;2016:8376979.全文  摘要

47. Ungprasert P, Srivali N, Kittanamongkolchai W. Risk of venous thromboembolism in patients with Sjögren's syndrome: a systematic review and meta-analysis. Clin Exp Rheumatol. 2015 Sep-Oct;33(5):746-50. 摘要

48. Aviña-Zubieta JA, Jansz M, Sayre EC, et al. The Risk of Deep Venous Thrombosis and Pulmonary Embolism in Primary Sjögren Syndrome: A General Population-based Study. J Rheumatol. 2017 Aug;44(8):1184-1189.全文  摘要

49. Chung WS, Lin CL, Sung FC, et al. Increased risks of deep vein thrombosis and pulmonary embolism in Sjogren syndrome: a nationwide cohort study. J Rheumatol. 2014 May;41(5):909-15. 摘要

50. Tsai YD, Chien WC, Tsai SH, et al. Increased risk of aortic aneurysm and dissection in patients with Sjögren's syndrome: a nationwide population-based cohort study in Taiwan. BMJ Open. 2018 Sep 21;8(9):e022326.全文  摘要

51. Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002 Jun;61(6):554-8.全文  摘要

52. Colella G, Cannavale R, Vicidomini A, et al. Salivary gland biopsy: a comprehensive review of techniques and related complications. Rheumatology (Oxford). 2010 Nov;49(11):2117-21. 摘要

53. Jonsson MV, Baldini C. Major salivary gland ultrasonography in the diagnosis of Sjogren’s syndrome - a place in the diagnostic criteria? Rheum Dis Clin North Am. 2016 Aug;42(3):501-17. 摘要

54. Zhang X, Zhang S, He J, et al. Ultrasonographic evaluation of major salivary glands in primary Sjogren's syndrome: comparison of two scoring systems. Rheumatology (Oxford). 2015 Sep;54(9):1680-7.全文  摘要

55. Luciano N, Baldini C, Tarantini G, et al. Ultrasonography of major salivary glands: a highly specific tool for distinguishing primary Sjogren's syndrome from undifferentiated connective tissue diseases. Rheumatology (Oxford). 2015 Dec;54(12):2198-204. 摘要

56. Takagi Y, Sumi M, Nakamura H, et al. Ultrasonography as an additional item in the American College of Rheumatology classification of Sjogren's syndrome. Rheumatology (Oxford). 2014 Nov;53(11):1977-83.全文  摘要

57. Barendregt PJ, Visser MR, Smets EM, et al. Fatigue in primary Sjogren's syndrome. Ann Rheum Dis. 1998 May;57(5):291-5.全文  摘要

58. Gudbjornsson B, Broman JE, Hetta J, et al. Sleep disturbances in patients with primary Sjogren's syndrome. Br J Rheumatol. 1993 Dec;32(12):1072-6. 摘要

59. Strombeck B, Ekdahl C, Manthorpe R, et al. Physical capacity in women with primary Sjogren's syndrome: a controlled study. Arthritis Rheum. 2003 Oct 15;49(5):681-8. 摘要

60. Newbrun E. Current treatment modalities of oral problems of patients with Sjogren's syndrome: caries prevention. Adv Dent Res. 1996 Apr;10(1):29-34. 摘要

61. Pedersen AM, Bardow A, Nauntofte B. Salivary changes and dental caries as potential oral markers of autoimmune salivary gland dysfunction in primary Sjogren's syndrome. BMC Clin Pathol. 2005 Mar 1;5(1):4.全文  摘要

62. Tucci M, Quatraro C, Silvestris F. Sjogren's syndrome: an autoimmune disorder with otolaryngological involvement. Acta Otorhinolaryngol Ital. 2005 Jun;25(3):139-44.全文  摘要

63. Segerberg-Konttinen M, Konttinen YT, Bergroth V. Focus score in the diagnosis of Sjogren's syndrome. Scand J Rheumatol Suppl. 1986;61:47-51. 摘要

64. Whitcher JP, Shiboski CH, Shiboski SC, et al; Sjogren's International Collaborative Clinical Alliance Research Groups. A simplified quantitative method for assessing keratoconjunctivitis sicca from the Sjogren's Syndrome International Registry. Am J Ophthalmol. 2010 Mar;149(3):405-15. 摘要

65. Daniels TE, Benn DK. Is sialography effective in diagnosing the salivary component of Sjogren's syndrome? Adv Dent Res. 1996 Apr;10(1):25-8. 摘要

66. Nicholson DA. Contrast media in sialography: a comparison of Lipiodol Ultra Fluid and Urografin 290. Clin Radiol 1990 Dec;42(6):423-6. 摘要

67. Hernández-Molina G, Avila-Casado C, Nuñez-Alvarez C, et al. Utility of the American-European Consensus Group and American College of Rheumatology Classification Criteria for Sjogren's syndrome in patients with systemic autoimmune diseases in the clinical setting. Rheumatology (Oxford). 2015 Mar;54(3):441-8. 摘要

68. Shiboski S, Shiboski C; EULAR Sjogren’s Syndrome Classification Criteria Working Group. Proposed ACR-EULAR classification criteria for Sjogren’s syndrome: development and validation. Abstract S1.1. 13th International Symposium on Sjogren’s Syndrome, May 2015; Bergen, Norway. [internet publication].全文

69. Shiboski CH. New ACR-EULAR Sjogren’s syndrome classification criteria and updates. Abstract. American College of Rheumatology National Meeting, September 2015; San Francisco, CA.

70. Ramos-Casals M, Tzioufas AG, Stone JH, et al. Treatment of primary Sjogren syndrome: a systematic review. JAMA. 2010 Jul 28;304(4):452-60.全文  摘要

71. Kalk WW, Mansour K, Vissink A, et al. Oral and ocular manifestations in Sjogren's syndrome. J Rheumatol. 2002 May;29(5):924-30. 摘要

72. Samarkos M, Moutsopoulos HM. Recent advances in the management of ocular complications of Sjogren's syndrome. Curr Allergy Asthma Rep. 2005 Jul;5(4):327-32. 摘要

73. Jacobi C, Cursiefen C. Ophthalmological complications in Sjogren's syndrome [in German]. Z Rheumatol. 2010 Feb;69(1):32-40. 摘要

74. Ramos-Casals M, Brito-Zerón P, Sisó-Almirall A, et al. Punctal occlusion in Sjogren's syndrome needs clarification. Nat Rev Rheumatol. 2012;8:752. 摘要

75. Zandbelt MM, van den Hoogen FH, de Wilde PC, et al. Reversibility of histological and immunohistological abnormalities in sublabial salivary gland biopsy specimens following treatment with corticosteroids in Sjogren's syndrome. Ann Rheum Dis. 2001 May;60(5):511-3. 摘要

76. Mavragani CP, Moutsopoulos HM. Conventional therapy of Sjogren's syndrome. Clin Rev Allergy Immunol. 2007 Jun;32(3):284-91. 摘要

77. Mavragani CP, Moutsopoulos HM. Immunosuppression and immunomodulation in Sjogren’s syndrome - what is the evidence? Does it relieve the sicca symptoms? Aktuelle Rheumatologie. 2005;30:66-70.

78. Fox PC, Datiles M, Atkinson JC, et al. Prednisone and piroxicam for treatment of primary Sjogren’s syndrome. Clin Exp Rheumatol. 1993 Mar-Apr;11(2):149-56. 摘要

79. Akpek EK, Lindsley KB, Adyanthaya RS, et al. Treatment of Sjogren's syndrome-associated dry eye: an evidence-based review. Ophthalmology. 2011 Jul;118(7):1242-52. 摘要

80. Gündüz K, Ozdemir O. Topical cyclosporin treatment of keratoconjunctivitis sicca in secondary Sjogren’s syndrome. Acta Ophthalmol (Copenh). 1994 Aug;72(4):438-42. 摘要

81. Fan WS, Hung HL, Liao HP, et al. Topical cyclosporine therapy for keratoconjunctivitis sicca in Sjogren’s syndrome. Tzu Chi Med J. 2003;15:85-89.

82. Drosos AA, Skopouli FN, Galanopoulu VK, et al. Cyclosporin A therapy in patients with primary Sjogren's syndrome: results at one year. Scand J Rheumatol Suppl. 1986;61:246-9. 摘要

83. Drosos AA, Skopouli FN, Costopoulos JS, et al. Cyclosporin A (CyA) in primary Sjogren’s syndrome: a double blind study. Ann Rheum Dis. 1986 Sep;45(9):732-5.全文  摘要

84. Skopouli FN, Jagiello P, Tsifetaki N, et al. Methotrexate in primary Sjogren's syndrome. Clin Exp Rheumatol. 1996 Sep-Oct;14(5):555-8. 摘要

85. Boumba D, Skopouli FN, Moutsopoulos HM. Cytokine mRNA expression in the labial salivary gland tissues from patients with primary Sjogren's syndrome. Br J Rheumatol. 1995 Apr;34(4):326-33. 摘要

86. Thanou-Stavraki A, James JA. Primary Sjogren's syndrome: current and prospective therapies. Semin Arthritis Rheum. 2008 Apr;37(5):273-92. 摘要

87. Touma Z, Sayad J, Arayssi T. Successful treatment of Sjogren's syndrome with rituximab. Scand J Rheumatol. 2006 Jul-Aug;35(4):323-5. 摘要

88. Devauchelle-Pensec V, Mariette X, Jousse-Joulin S, et al. Treatment of primary Sjogren syndrome with rituximab: a randomized trial. Ann Intern Med. 2014 Feb 18;160(4):233-42. 摘要

89. Gottenberg JE, Ravaud P, Puéchal X, et al. Effects of hydroxychloroquine on symptomatic improvement in primary Sjogren syndrome: the JOQUER randomized clinical trial. JAMA. 2014 Jul 16;312(3):249-58.全文  摘要

90. Manoussakis MN, Moutsopoulos HM. Anti-malarials in Sjogren's syndrome - the Greek experience. Lupus. 1996;5(suppl 1):28S-30S. 摘要

91. Scofield RH. Vasculitis in Sjogren's Syndrome. Curr Rheumatol Rep. 2011 Dec;13(6):482-8. 摘要

92. Doyle MK. Vasculitis associated with connective tissue disorders. Curr Rheumatol Rep. 2006 Aug;8(4):312-6. 摘要

93. Wakasugi D, Kato T, Gono T, et al. Extreme efficacy of intravenous immunoglobulin therapy for severe burning pain in a patient with small fiber neuropathy associated with primary Sjogren's syndrome. Mod Rheumatol. 2009;19(4):437-40. 摘要

94. Rist S, Sellam J, Hachulla E, et al. Experience of intravenous immunoglobulin therapy in neuropathy associated with primary Sjogren's syndrome: a national multicentric retrospective study. Arthritis Care Res (Hoboken). 2011 Sep;63(9):1339-44. 摘要

95. Morozumi S, Kawagashira Y, Iijima M, et al. Intravenous immunoglobulin treatment for painful sensory neuropathy associated with Sjogren's syndrome. J Neurol Sci. 2009 Apr 15;279(1-2):57-61. 摘要

96. Porter SR, Scully C, Hegarty AM. An update of the etiology and management of xerostomia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004 Jan;97(1):28-46. 摘要

97. O'Neill ID, Scully C. Biologics in oral medicine: Sjogren syndrome. Oral Dis. 2013 Mar;19(2):121-7. 摘要

98. Izumi M, Eguchi K, Nakamura H, et al. Corticosteroid irrigation of parotid gland for treatment of xerostomia in patients with Sjogren's syndrome. Ann Rheum Dis. 1998 Aug;57(8):464-9.全文  摘要

99. Aragona P, Spinella R, Rania L, et al. Safety and efficacy of 0.1% clobetasone butyrate eyedrops in the treatment of dry eye in Sjogren syndrome. Eur J Ophthalmol. 2013 May-Jun;23(3):368-76. 摘要

100. Pan Q, Angelina A, Marrone M, et al. Autologous serum eye drops for dry eye. Cochrane Database Syst Rev. 2017;(2):CD009327.全文  摘要

101. López-García JS, García-Lozano I, Rivas L, et al. Autologous serum eye drops diluted with sodium hyaluronate: clinical and experimental comparative study. Acta Ophthalmol. 2014 Feb;92(1):e22-9.全文  摘要

102. Ba J, Wu Y, Li Y, et al. Updated meta-analysis of acupuncture for treating dry eye. Med Acupuncture. 2013;25:317-327.

103. Vivino FB, Al-Hashimi I, Khan Z, et al; P92-01 Study Group. Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sjogren syndrome: a randomized, placebo-controlled, fixed-dose, multicenter trial. Arch Intern Med. 1999 Jan 25;159(2):174-81.全文  摘要

104. Voulgarelis M, Skopouli FN. Clinical, immunologic, and molecular factors predicting lymphoma development in Sjogren's syndrome patients. Clin Rev Allergy Immunol. 2007 Jun;32(3):265-74. 摘要

105. Fox RI. Sjogren's syndrome: current therapies remain inadequate for a common disease. Expert Opin Investig Drugs. 2000 Sep;9(9):2007-16. 摘要

106. Mariette X. Lymphomas complicating Sjogren's syndrome and hepatitis C virus infection may share a common pathogenesis: chronic stimulation of rheumatoid factor B cells. Ann Rheum Dis. 2001 Nov;60(11):1007-10.全文  摘要

107. Lynch DA. Lung disease related to collagen vascular disease. J Thorac Imaging. 2009 Nov;24(4):299-309. 摘要